Log in to save to my catalogue

Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cad6e99b695d4c66a9002c62027f15b1

Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

About this item

Full title

Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-11, Vol.12 (1), p.6912-16, Article 6912

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite their limitations, unfractionated heparin (UFH) and bivalirudin remain standard-of-care parenteral anticoagulants for percutaneous coronary intervention (PCI). We discovered novel direct thrombin inhibitors (DTIs) from tick salivary transcriptomes and optimised their pharmacologic activity. The most potent, ultravariegin, inhibits thrombin...

Alternative Titles

Full title

Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cad6e99b695d4c66a9002c62027f15b1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cad6e99b695d4c66a9002c62027f15b1

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-27275-8

How to access this item